Search Tips
of 1 Next >
Results Found: 8
  • Liver Hepatocellular Adenoma and Carcinomas (MSK, PLOS One 2018): Targeted sequencing of tumor/normal pairs of 9 LIAD and 10 HCC patients via MSK-IMPACT platform.

    Description

    This dataset contains summary data visualizations and clinical data from a broad sampling of hepatocellular adenomas and carcinomas. The data was gathered utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes tumor type (based on the opensource OncoTree ontology developed at MSK), Patient ID, Sample ID, Cancer Type Detailed, Mutation Count, Fraction Genome Altered, Collaboration...

    Subject
    Adenoma, Liver Cell
    Carcinoma, Hepatocellular
    DNA Mutational Analysis
    Liver Neoplasms
    Access Rights
    Free to All
  • Hepatocellular Carcinoma (MSK, Clin Cancer Res 2018): MSK-IMPACT sequencing of 127 Hepatocellular Carcinoma tumor samples with matched normals.

    Description

    This dataset contains summary data visualizations and clinical data from a broad sampling of hepatocellular carcinomas. The data was gathered utilizing the MSK-IMPACT targeted sequencing test. The clinical data includes mutation count, information about mutated genes, patient demographics, modality details, and disease status. The data set also includes copy-number segment data downloadable as .seg...

    Subject
    Carcinoma, Hepatocellular
    DNA Mutational Analysis
    Immunotherapy
    Liver Neoplasms
    Access Rights
    Free to All
  • Liver Hepatocellular Carcinoma

    Description

    TCGA Liver Hepatocellular Carcinoma. Source data from GDAC Firehose. Previously known as TCGA Provisional. This dataset contains summary data visualizations and clinical data from a broad sampling of 442 carcinomas from 440 patients. The data was gathered as part of the Broad Institute of MIT and Harvard Firehose initiative, a cancer analysis pipeline. The clinical data includes mutation count, information...

    Subject
    Carcinoma, Hepatocellular
    DNA Mutational Analysis
    Liver Neoplasms
    Access Rights
    Free to All
  • Intrahepatic Cholangiocarcinoma (MSK, Hepatology 2021): Targeted sequencing of 412 intrahepatic cholangiocarcinoma tumor/normal sample pairs.

    Description

    This dataset contains summary data visualizations and clinical data from a broad sampling of 412 intrahepatic cholangiocarcinomas from 412 patients. The clinical data includes mutation count, information about mutated genes, patient demographics, adjuvant chemotherapy, patient BMI, Duct Type, DZ Extent, CA19, CA19 High, and presence of chronic viral hepatitis, cirrhosis, diabetes, ECOG BIN, HAIC,...

    Subject
    Cholangiocarcinoma
    DNA Mutational Analysis
    Liver Neoplasms
    Access Rights
    Free to All
  • Intrahepatic Cholangiocarcinoma: Targeted sequencing of IMPACT and CMO samples

    Description

    This dataset contains summary data visualizations and clinical data from a sampling of 219 intrahepatic cholangiocarcinomas from 219 patients. The clinical data includes mutation count, presence of an Archer Panel, MSK IMPACT TMB Percentiles across & within tumor types, Metastatic Sites and the availability of MSK Pathology slide, Mutation Count, Age at Which Sequencing was Reported, Archer Panel,...

    Subject
    Adenocarcinoma
    Cholangiocarcinoma
    DNA Mutational Analysis
    Liver Neoplasms
    Access Rights
    Free to All
  • Genomic and Transcriptomic Landscape of Fibrolamellar Hepatocellular Carcinoma

    Authors
    Simon, Sanford M.
    Description

    Study Description from dbGaP: "Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare liver tumor primarily affecting adolescents and young adults. Little is known of the molecular pathogenesis. To characterize the disease we performed RNA sequencing and whole genome sequencing on FL-HCC tumors and adjacent normal tissue. The results demonstrate few consistent differences on the chromosomal level...

    Subject
    Carcinoma, Hepatocellular
    Liver Neoplasms
    Access Rights
    Application Required
  • KDM6A(UTX) is an epigenetic gatekeeper of mTORC1 signalling in cancer

    Authors
    Revia, Steffie
    Tschaharganeh, Darjus F.
    Description

    Summary from GEO: "Large-scale genome sequencing efforts of human tumors identified epigenetic modifiers as one of the most frequently mutated gene class in human cancer. However, how these mutations drive tumor development and progression is largely unknown. Here, we identify the histone demethylase KDM6A as an important tumor suppressor in solid cancers, such as liver cancer and pancreatic cancer....

    Subject
    Histone Demethylases
    Liver Neoplasms
    Mechanistic Target of Rapamycin Complex 1
    Pancreatic Neoplasms
    Access Rights
    Free to All
  • Surface proteome profiling of p53-restorable murine liver cancer cells

    Authors
    Ho, Yu-jui
    Lowe, Scott W.
    Description

    Characterization of the surface proteome changes between proliferating and senescent liver cancer cells induced by p53 restoration.

    Subject
    Liquid Chromatography-Mass Spectrometry
    Liver Neoplasms
    Proteome
    Tumor Suppressor Protein p53
    Access Rights
    Free to All